Table 2. Adverse event of leflunomide treatment of each case.
| Case No. | Adverse event |
Remarks | |
|---|---|---|---|
| Clinical symptoms (day) | Blood exam (day) | ||
| 1 | |||
| 2 | Lethargy (333) | WBC: 17,100/ml, ALP 732 U/l, CRP: 1.3 mg/dl (333) | Cholecyctitis was suspected |
| 3 | |||
| 4 | ALP: 855 U/l (35) | ||
| 5 | ALP: 6,689 U/l, ALT: 211 U/l (28) | ||
| 6 | ALP: 775 U/l, ALT: 143 U/l (21) | ||
| 7 | ALP: 946 U/l (33) | ||
| 8 | ALP: 2,643 U/l, ALT: 97 U/l (34) | ||
| 9 | Lethargy (77) | Hct: 17% (77) | |
| 10 | ALP: 343 U/l, ALT: 90 U/l (20) | ||
| 11 | WBC: 4,400 /ml (392) | ||
| 12 | |||
| 13 | Lethargy, Anorexia, Dyspnea, Cough (32) | WBC: 1,600 /ml, PLT: 87,000 /ml, CRP: 8.6 mg/dl (32) | Infectious respiratory disease was suspected |
| 14 | |||
| 15 | ALP: 241 U/l (28) | ||